CIK 0001651308
- Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981209416
- Phone
- +41 616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 32 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-14 | BAKER BROS. ADVISORS LP Director | Option exercise | +30,768 | $36.83 | $1.1M | 761,410 |
| 2026-09-14 | BAKER BROS. ADVISORS LP Director | Option exercise | +30,768 | $36.83 | $1.1M | 8,099,179 |
| 2026-09-14 | BAKER BROS. ADVISORS LP Director | Option exercise · Non-Qualified Share Options | −30,768 | 0 | ||
| 2026-09-14 | BAKER BROS. ADVISORS LP Director | Option exercise · Non-Qualified Share Options | −30,768 | 0 | ||
| 2026-06-11 | BAKER BROS. ADVISORS LP Director | Grant or award | +18,980 | 161,546 | ||
| 2026-06-11 | BAKER BROS. ADVISORS LP Director | Grant or award | +18,980 | 161,550 | ||
| 2026-05-22 | BAKER BROS. ADVISORS LP Director | Sale | −2,743 | $23.85 | $65K | 145,322 |
| 2026-05-22 | BAKER BROS. ADVISORS LP Director | Sale | −2,743 | $23.85 | $65K | 145,326 |
| 2026-05-22 | BAKER BROS. ADVISORS LP Director | Sale | −2,756 | $23.79 | $66K | 142,566 |
| 2026-05-22 | BAKER BROS. ADVISORS LP Director | Sale | −2,756 | $23.79 | $66K | 142,570 |
| 2025-05-21 | BAKER BROS. ADVISORS LP Director | Grant or award | +21,970 | 148,065 | ||
| 2025-05-21 | BAKER BROS. ADVISORS LP Director | Grant or award | +21,970 | 148,069 | ||
| 2025-05-21 | BAKER BROS. ADVISORS LP Director | Grant or award · Share Option (Right to Buy) | +45,500 | 45,500 | ||
| 2025-05-21 | BAKER BROS. ADVISORS LP Director | Grant or award · Share Option (Right to Buy) | +45,500 | 45,500 | ||
| 2025-02-28 | BAKER BROS. ADVISORS LP Director | Sale | −60,851 | $260.00 | $15.8M | 730,642 |
| 2025-02-28 | BAKER BROS. ADVISORS LP Director | Sale | −671,976 | $260.00 | $174.7M | 8,068,411 |
| 2024-12-09 | BAKER BROS. ADVISORS LP Director | Sale | −3,074 | $208.01 | $639K | 874,529 |
| 2024-12-09 | BAKER BROS. ADVISORS LP Director | Sale | −33,943 | $208.01 | $7.1M | 9,657,351 |
| 2024-12-09 | BAKER BROS. ADVISORS LP Director | Sale | −83,036 | $186.50 | $15.5M | 791,493 |
| 2024-12-09 | BAKER BROS. ADVISORS LP Director | Sale | −916,964 | $186.50 | $171.0M | 8,740,387 |
Page 1 of 4 · 65 trades